BCM
AMRX icon

Bridgeway Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bridgeway Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Sell
106,449
-5,000
-4% -$67.1K 0.03% 642
2025
Q4 		$1.4M Buy
+111,449
New +$1.28M 0.03% 633
2021
Q4 		– Sell
-83,200
Closed -$444K – 1261
2021
Q3 		$444K Hold
83,200
– – 0.01% 1070
2021
Q2 		$426K Sell
83,200
-12,400
-13% -$70.5K 0.01% 1115
2021
Q1 		$643K Sell
95,600
-186,800
-66% -$1.04M 0.01% 1025
2020
Q4 		$1.29M Buy
282,400
+18,400
+7% +$81.5K 0.03% 684
2020
Q3 		$1.02M Buy
264,000
+18,500
+8% +$79.1K 0.02% 673
2020
Q2 		$1.17M Buy
+245,500
New +$1.01M 0.02% 607

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return